What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

Company

Indicator

Code Company Date Close Change Indicator Value Signal

Trading Performance

Simple Moving Average

Score

-1.05

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 44 9.1 0.23% 0.29% 36.0% -3.7% 229.8%
SHORT 43 8.8 0.26% 0.31% 3.4% -3.5% -89.1%

Summary

Technical Analysis

Opthea (OPT.AX)


Indicator:

SIMPLE MOVING AVERAGE


Last Signal:

BULLISH


Trading: BUY @ $3.52
Signal Strength: STRONG
Recommendation:

Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has the ability to highlight trends across numerous timeframes. This indicator has the ability to smooth historical results to illustrate trend initiation and status. Although this is a simple trend following indicator & can provide good results when coupled with the right indicator. Note, this indicator does not work well in ranging markets producing unwanted whipsaws and false signals.


Opthea (ASX:OPT) currently has a confirmed uptrend. This means the SMA 15 day average has exceeded the closing price confirming the short term trend following indicator. Currently, the return on SMA15 is 4.5%.



A simple moving average is formed by computing the average price of a security over a specific number of periods. Most moving averages are based on closing prices.

Calculation: Simple Moving Average:
1) SMA: n period sum / n;


PROFILE: Opthea (OPT.AX)


Stock Exchange: ASX
Company: Opthea
Ticker Codes: | OPT.AX | ASX:OPT |

About Opthea (ASX:OPT):

Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3, which is in Phase 1/2A clinical trial for the treatment of back of the eye diseases, such as wet age-related macular degeneration that is the cause of blindness in elderly and diabetic populations. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited is based in South Yarra, Australia.

Top 10:

Simple Moving Average

Download
Company Close Change(%) Volume Value Signal
MSB Mesoblast 2.91 10.2 4,870,990 3.5 BULLISH
ECX Eclipx 1.54 7.3 2,538,019 15.1 BULLISH
KSC K&S Corporation 1.6 6 9,657 4.3 BULLISH
FMG Fortescue Metals 12.69 5 21,508,010 3.3 BULLISH
PPH Pan Pharmaceuticals 4.35 4.1 140,308 2.5 BULLISH
RXP Rxp Services 0.56 3.7 121,824 6.4 BULLISH
OSP Osprey Medical 0.03 3.7 57,495 6.7 BULLISH
NEA Nearmap 2.62 3.6 3,668,519 7.1 BULLISH
IFT Infratil 5.39 3.5 17,293 3.8 BULLISH
IRE Iress Market Technology 13.73 3.5 449,191 0.9 BULLISH